Tumours can escape immune surveillance through suppression of CD95 signalling, release of soluble decoy receptors to bind to and inactivate FasL on immune cells1 and may even induce apoptosis in immune effectors directly by expressing FasL themselves. Here, FAS is linked to neoplasm.